Support 100 years of independent journalism.

Advertorial feature by Bristol-Myers Squibb
  1. Politics
10 May 2017updated 09 Sep 2021 5:29pm

Breaking the Cycle of Cancer Care

This article is produced and funded by Bristol-Myers Squibb with support from The Patients Association.

By Bristol-Myers Squibb

Cancer prevalence in the UK is increasing; current estimates show that one in two of us born after 1960 will turn to the NHS for a form of cancer treatment at one point in our livesi. However, the UK allocates much less of its health spending to cancer (3.8%) than the EU average (5%) and survival lags behind much of Europe.
Whilst the NHS has set itself the target of radically improving cancer outcomes over the next five years, it is likely that this target will have to be achieved without significant extra investment. This squeeze on NHS resources can lead to a negative cycle in cancer care, where too often a short term approach that focuses on immediate pressures can often lead to longer term costs, resulting in fewer resources being available.ii
In order to support the NHS to radically improve patient outcomes iii , we need to break the negative cycle in cancer care. To address this challenge, Bristol-Myers Squibb and the Patients Association are working alongside experts and patients from across the cancer space to identify new models of service delivery, showcase best practice, and provide real improvements in patient care.

Job bag: ONCUK1700375-01
Date of preparation: April 2017

Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born in 1930 to 1960. Br J Cancer 2015; 112: 943-947

ii Cole, A, Lundqvist A, Lorgelly P, et al. Office of Health Economic and Swedish Institute for Health Economics, 2016. Improving Efficiency and Resource Allocation in Future Cancer Care. Available here: (Accessed: September 2016).

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s global affairs newsletter, every Monday and Friday. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

Independent Cancer Taskforce, 2015. Achieving World-Class Cancer Outcomes a Strategy for England 2015-2020, available here: [Accessed February 2017]

Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born in 1930 to 1960. Br J Cancer 2015; 112: 943-947
Cole, A, Lundqvist A, Lorgelly P, et al. Office of Health Economic and Swedish Institute for Health Economics, 2016. Improving Efficiency and Resource Allocation in Future Cancer Care. Available at: https://www.ohe.org/publications/improving-efficiency-and-resource-allocation-future-cancer-care (Accessed: September 2016).

iii Independent Cancer Taskforce, 2015. Achieving World-Class Cancer Outcomes a Strategy for England 2015-2020, available here: [Accessed February 2017]

Topics in this article: